Insider · CIK 0001789970

Hanson Kristopher

Reports to the SEC for 2 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001789970

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-15	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−9,020 sh	$8.08	−$72.9K	128,024
2026-09-16	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−16.5K sh	$11.67	−$193K	137,044
2026-08-17	MPLTMapLight Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	General Counsel	AAward	+31.4K sh	—	—	31,395
2026-08-17	MPLTMapLight Therapeutics, Inc.A Award	General Counsel	AAward	+7,730 sh	—	—	153,553
2026-07-17	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−1,130 sh	$37.90	−$42.8K	145,823
2026-07-16	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−3,331 sh	$37.26	−$124K	146,964
2026-07-16	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−11 sh	$37.96	−$417.56	146,953
2026-07-16	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−4,776 sh	$36.45	−$174K	150,295
2026-07-15	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−5,103 sh	$36.99	−$189K	155,081
2026-07-15	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−10 sh	$37.54	−$375.4	155,071
2026-07-15	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−2,147 sh	$36.00	−$77.3K	160,184
2026-05-11	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−5,808 sh	$30.56	−$177K	162,331
2026-05-11	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−284 sh	$27.61	−$7,841.24	175,964
2026-05-11	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−846 sh	$28.70	−$24.3K	175,118
2026-05-11	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−6,979 sh	$30.04	−$210K	168,139
2026-05-04	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−9,030 sh	$27.50	−$248K	181,135
2026-05-04	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−296 sh	$29.56	−$8,749.76	176,931
2026-05-04	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−683 sh	$30.08	−$20.5K	176,248
2026-05-04	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−3,908 sh	$28.29	−$111K	177,227
2026-04-16	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−73 sh	$27.01	−$1,971.73	190,390
2026-04-16	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−225 sh	$27.49	−$6,185.25	190,165
2026-04-15	MPLTMapLight Therapeutics, Inc.S Sale	General Counsel	SSale	−1,529 sh	$26.80	−$41K	190,463
2026-02-05	MPLTMapLight Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	General Counsel	AAward	+31.4K sh	—	—	31,395
2026-02-05	MPLTMapLight Therapeutics, Inc.A Award	General Counsel	AAward	+7,730 sh	—	—	191,582
2026-01-27	MPLTMapLight Therapeutics, Inc.F Tax Payment	General Counsel	FTax Payment	−26K sh	$17.98	−$468K	183,852
2025-10-27	MPLTMapLight Therapeutics, Inc.A Award	General Counsel	AAward	+27.1K sh	—	—	27,098
2025-10-27	MPLTMapLight Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	General Counsel	AAward	+110K sh	—	—	110,046
2022-05-20	PhaseBio Pharmaceuticals IncA Award	SVP and General Counsel	AAward	+4,831 sh	$0.68	+$3,291.36	8,463
2022-02-24	PhaseBio Pharmaceuticals IncRestricted Stock UnitA Award	SVP and General Counsel	AAward	+18.8K sh	—	—	18,750
2022-02-24	PhaseBio Pharmaceuticals IncEmployee Stock Option (right to buy)A Award	SVP and General Counsel	AAward	+87.5K sh	—	—	87,500
2021-11-19	PhaseBio Pharmaceuticals IncA Award	SVP and General Counsel	AAward	+1,545 sh	$2.01	+$3,105.45	3,632
2021-05-20	PhaseBio Pharmaceuticals IncA Award	SVP and General Counsel	AAward	+1,088 sh	$2.80	+$3,046.4	2,087
2021-02-05	PhaseBio Pharmaceuticals IncEmployee Stock Option (right to buy)A Award	SVP and General Counsel	AAward	+36K sh	—	—	36,000
2020-11-20	PhaseBio Pharmaceuticals IncA Award	SVP and General Counsel	AAward	+999 sh	$3.00	+$2,997	999
2020-02-12	PhaseBio Pharmaceuticals IncEmployee Stock Option (right to buy)A Award	SVP and General Counsel	AAward	+55K sh	—	—	55,000
2019-10-07	PhaseBio Pharmaceuticals IncEmployee Stock Option (right to buy)A Award	SVP and General Counsel	AAward	+66K sh	—	—	66,000

Recent filings

Accepted (ET)
Oct 16 17:004
Hanson Kristopher0001789970-26-000018
SEC(opens sec.gov)
Sep 184
Hanson Kristopher0001789970-26-000016
SEC(opens sec.gov)
Aug 194
Hanson Kristopher0001789970-26-000014
SEC(opens sec.gov)
Jul 174
Hanson Kristopher0001789970-26-000012
SEC(opens sec.gov)
May 114
Hanson Kristopher0001789970-26-000010
SEC(opens sec.gov)
May 64
Hanson Kristopher0001789970-26-000008
SEC(opens sec.gov)
Apr 174
Hanson Kristopher0001789970-26-000006
SEC(opens sec.gov)

Companies

Address

C/O MAPLIGHT THERAPEUTICS, INC. 800 CHESAPEAKE DRIVE

REDWOOD CITY, CA, 94063